Respiratory Medicine
Volume 104, Issue 4 , Pages 542-549 , April 2010

Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype

  • Ji-Hyun Lee

      Affiliations

    • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Bundang CHA Hospital, College of Medicine, CHA University, Seongnam, South Korea
    • ,
  • Young Kyung Lee

      Affiliations

    • Department of Radiology, East-West Neo Medical Center, Kyunghee University, Seoul, South Korea
    • ,
  • Eun-Kyung Kim

      Affiliations

    • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Bundang CHA Hospital, College of Medicine, CHA University, Seongnam, South Korea
    • ,
  • Tae-Hyung Kim

      Affiliations

    • Division of Pulmonology, Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, South Korea
    • ,
  • Jin Won Huh

      Affiliations

    • Department of Internal Medicine, Ilsan Paik Hospital, Inje University, Goyang, South Korea
    • ,
  • Woo Jin Kim

      Affiliations

    • Department of Internal Medicine, College of Medicine, Kangwon National University, Chuncheon, South Korea
    • ,
  • Jin Hwa Lee

      Affiliations

    • Department of Internal Medicine, Ewha Womans University Mokdong Hospital, College of Medicine, Ewha Womans University, Seoul, South Korea
    • ,
  • Sang-Min Lee

      Affiliations

    • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Clinical Research Institute, Seoul National University Hospital, Lung Institute, Medical Research Center, Seoul National University College of Medicine, Seoul, South Korea
    • ,
  • Sangyeub Lee

      Affiliations

    • Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Korea University Anam Hospital, Seoul, South Korea
    • ,
  • Seong Yong Lim

      Affiliations

    • Division of Pulmonary and Critical Care Medicine, Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea
    • ,
  • Tae Rim Shin

      Affiliations

    • Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea
    • ,
  • Ho Il Yoon

      Affiliations

    • Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea
    • ,
  • Seung Soo Sheen

      Affiliations

    • Department of Pulmonary and Critical Care Medicine, Ajou University School of Medicine, Suwon, South Korea
    • ,
  • NamKug Kim

      Affiliations

    • Department of Radiology, and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
    • ,
  • Joon Beom Seo

      Affiliations

    • Department of Radiology, and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
    • ,
  • Yeon-Mok Oh

      Affiliations

    • Department of Pulmonary and Critical Care Medicine, and Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 388-1 Pungnap-dong, Sonpa-gu, Seoul 138-736, South Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82 2 3010 3136; fax: +82 2 3010 6968.
    • ,
  • Sang Do Lee

      Affiliations

    • Department of Pulmonary and Critical Care Medicine, and Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 388-1 Pungnap-dong, Sonpa-gu, Seoul 138-736, South Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82 2 3010 3140; fax: +82 2 3010 6968.

Received 22 June 2009 ,Accepted 28 October 2009.

References 

  1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease updated 2003. Bethesda, MD: National Heart, Lung and Blood Institute, World Health Organization; 2003.
  2. Burrows B, Fletcher CM, Heard BE, Jones NL, Wootliff JS. The emphysematous and bronchial types of chronic airways obstruction. A clinicopathological study of patients in London and Chicago. Lancet. 1966;1:830–835
  3. Calverley PMA, Bellamy D. The challenge of providing better care for patients with chronic obstructive pulmonary disease: the poor relation of airways obstruction?. Thorax. 2000;55:78–82
  4. O'Donnell RA, Peebles C, Ward JA, et al. Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax. 2004;59:837–842
  5. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004;364:709–721
  6. Callahan CM, Dittus RS, Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: a meta-analysis. Ann Intern Med. 1991;114:216–223
  7. Mahler D, Wells C. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93:580–586
  8. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories . ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–117
  9. Lee YK, Oh YM, Lee JH, et al. KOLD Study Group Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung. 2008;186:157–165
  10. American Thoracic Society . Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152:1107–1136
  11. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European Respiratory Society. Eur Respir J. 1993;16:S5–S40
  12. American Thoracic Society . Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique: 1995 update. Am J Respir Crit Care Med. 1995;152:2185–2198
  13. Snoeck-Stroband JB, Lapperre TS, Gosman MM, et al. Groningen Leiden Universities Corticosteroids in Obstructive Lung Disease (GLUCOD) study group Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies. Eur Respir J. 2008;31:70–77
  14. Kitaguchi Y, Fujimoto K, Kubo K, Honda T. Characteristics of COPD phenotypes classified according to the findings of HRCT. Respir Med. 2006;100:1742–1752
  15. Fujimoto K, Kitaguchi Y, Kubo K, Honda T. Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomography. Respirology. 2006;11:731–740
  16. Pistolesi M, Camiciottoli G, Paoletti M, et al. Identification of a predominant COPD phenotype in clinical practice. Respir Med. 2008;102:367–376
  17. Boschetto P, Quintavalle S, Zeni E, et al. Association between markers of emphysema and more severe chronic obstructive pulmonary disease. Thorax. 2006;61:1037–1042
  18. Buist AS, Connett JE, Miller RD, Kanner RE, Owens GR, Voelker HT Chronic Obstructive Pulmonary Disease early intervention trial (Lung Health Study). Baseline characteristics of randomized participants. Chest. 1993;103:1863–1872
  19. Nakano Y, Muro S, Sakai H, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers: correlation with lung function. Am J Respir Crit Care Med. 2000;162:1102–1108
  20. de Jong PA, Muller NL, Pare PD, Coxson HO. Computed tomographic imaging of the airways: relationship to structure and function. Eur Respir J. 2005;26:140–152
  21. Hasegawa M, Nasuhara Y, Onodera Y, et al. Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;173:1309–1315
  22. King GG, Muller NL, Whittall KP, Xiang QS, Pare PD. An analysis algorithm for measuring airway lumen and wall areas from high resolution computed tomographic data. Am J Respir Crit Care Med. 2000;161:574–580
  23. Gevenois PA, de Maertelaer V, De Vuyst P, Zanen J, Yernault JC. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med. 1995;152:653–657
  24. Gevenois PA, De Vuyst P, de Maertelaer V, et al. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med. 1996;154:187–192
  25. Madani A, Zanen J, de Maertelaer V, Gevenois PA. Pulmonary emphysema: objective quantification at multi-detector row CT–comparison with macroscopic and microscopic morphometry. Radiology. 2006;238:1036–1043
  26. Muller NL, Staples CA, Miller RR, Abboud RT. “Density mask”. An objective method to quantitate emphysema using computed tomography. Chest. 1988;94:782–787
  27. Makita H, Nasuhara Y, Betsuyaku T, Onodera Y, Hizawa N, Nishimura M Hokkaido COPD Cohort Study Group. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax. 2007;62:932–937
  28. Sanders C, Nath PH, Bailey WC. Detection of emphysema with computed tomography: correlation with pulmonary function tests and chest radiography. Invest Radiol. 1988;23:262–266
  29. Perng DW, Wu CC, Su KC, Lee YC, Perng RP, Tao CW. Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility. Lung. 2006;184:217–222
  30. Perng DW, Huang HY, Chen HM, Lee YC, Perng RP. Characteristics of airway inflammation and bronchodilator reversibility in COPD. Chest. 2004;126:375–381
  31. Tashkin D, Kesten S. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. Chest. 2003;123:1441–1449
  32. Calverley P, Pauwels R, Vestbo J, et al. Trial of inhaled steroids and long-acting beta2 agonists study group. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2003;361:449–456
  33. Calverley P, Anderson JA, Celli B, et al. TORCH investigators Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356:775–789

☆ Both authors contributed equally to this work with senior responsibilities.

PII: S0954-6111(09)00359-X

doi: 10.1016/j.rmed.2009.10.024

Respiratory Medicine
Volume 104, Issue 4 , Pages 542-549 , April 2010

Article Tools

* Image Usage & Resolution